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Intellectual disability is a prevalent disorder that
remains incurable. Mutations of the X-linked pro-
tein PHF6 cause the intellectual disability disorder
Bo¨rjeson-Forssman-Lehmann syndrome (BFLS).
However, the biological role of PHF6 relevant to
BFLS pathogenesis has remained unknown. We
report that knockdown of PHF6 profoundly impairs
neuronal migration in the mouse cerebral cortex
in vivo, leading to the formation of white matter het-
erotopias displaying neuronal hyperexcitability. We
find that PHF6 physically associates with the PAF1
transcription elongation complex, and inhibition of
PAF1 phenocopies the PHF6 knockdown-induced
migration phenotype in vivo. We also identify Neuro-
glycan C/Chondroitin sulfate proteoglycan 5 (NGC/
CSPG5), a potential schizophrenia susceptibility
gene, as a critical downstream target of PHF6 in the
control of neuronal migration. These findings define
PHF6, PAF1, and NGC/CSPG5 as components of a
cell-intrinsic transcriptional pathway that orches-
trates neuronal migration in the brain, with important
implications for the pathogenesis of developmental
disorders of cognition.
INTRODUCTION
Intellectual disability is a common developmental disorder
affecting 1%–3% of the general population (Bhasin et al.,
2006). The economic costs of intellectual disability are enor-
mous. No effective treatments are available for intellectual
disability, and thus there is an urgent need for improved under-
standing of these disorders. In recent years, mutations in many
genes have been identified that cause intellectual disability, but986 Neuron 78, 986–993, June 19, 2013 ª2013 Elsevier Inc.how these mutations trigger intellectual disability remains largely
to be elucidated.
Mutations of the X-linked gene encoding the protein PHF6
cause the Bo¨rjeson-Forssman-Lehmann syndrome (BFLS),
characterized by moderate to severe intellectual disability asso-
ciated variably with seizures (Lower et al., 2002). However, the
function of PHF6 relevant to BFLS pathogenesis has remained
unknown. Cognitive dysfunction is evident from a very early
age, suggesting that abnormal brain development contributes
to intellectual disability in BFLS patients (Turner et al., 2004).
Therefore, understanding PHF6’s role during brain development
should provide important insights into the pathogenesis of BFLS.
In this study, we have discovered a function for the X-linked
intellectual disability protein PHF6 in the development of the
cerebral cortex in vivo. Loss of PHF6 profoundly impairs
neuronal migration and, importantly, this impairment persists
beyond the developmental stage of corticogenesis, leading to
white matter heterotopias with aberrant neuronal activity. We
have also identified an intimate link between PHF6 and the
PAF1 transcription elongation complex that plays an essential
role in neuronal migration in the cerebral cortex. Finally, we
have identified Neuroglycan C/Chondroitin sulfate proteoglycan
5 (NGC/CSPG5) as a downstream target of PHF6 and the PAF1
complex in the control of neuronal migration. Our findings define
a pathophysiologically relevant cell-intrinsic transcriptional
pathway that orchestrates neuronal migration in the cerebral
cortex.
RESULTS
PHF6 Plays an Essential Role in Radial Neuronal
Migration in the Cerebral Cortex In Vivo
To interrogate PHF6 function in the mammalian brain, we first
characterized the expression of PHF6 in the developing cerebral
cortex. We found that PHF6 was highly expressed during early
phases of development in primary cortical neurons and in the
developing mouse brain (see Figures S1A and S1B available
online). PHF6 was broadly expressed in the mouse cerebral
Figure 1. PHF6 Plays an Essential Role in
Radial Neuronal Migration in the Cerebral
Cortex In Vivo
(A) Lysates of 293T cells transfected with an
expression plasmid encoding FLAG-PHF6
together with an RNAi plasmid encoding PHF6
shRNAs or control scrambled shRNAs were im-
munoblotted with the FLAG and 14-3-3b anti-
bodies. Two exposures (short and long) are shown
for PHF6. (B) Lysates of primary mouse cortical
neurons infected with lentivirus expressing PHF6
shRNAs or control shRNAs were immunoblotted
with the PHF6 and 14-3-3b antibodies. (C) E14
mouse embryos electroporated with an RNAi
plasmid encoding PHF6 shRNAs or control
shRNAs together with a GFP expression plasmid
were allowed to develop until E19. The cerebral
cortex from the E19 embryos was subjected to
immunohistochemical analyses with the PHF6 and
GFP antibodies. PHF6 RNAi induced robust
downregulation of PHF6 in cortical neurons in vivo
(arrowheads). (D) E14 mouse embryos were sub-
jected to in utero electroporation as in (C) and the
cerebral cortex of E19 embryos was analyzed by
immunohistochemistry using the GFP antibody.
The upper cortical plate (upCP), lower cortical
plate (loCP), intermediate zone (IZ), and ventricular
zone/subventricular zone (VZ/SVZ) are indicated.
(E) Quantification of the percentage of GFP-posi-
tive neurons in distinct regions of the cerebral
cortex in E19 mouse embryos treated as in (D) is
presented as mean + SEM. (F) Lysates of 293T
cells transfected with an expression plasmid en-
coding FLAG-rat PHF6 (PHF6-Res) or FLAG-
mouse PHF6 (PHF6-WT) together with the PHF6
RNAi or control RNAi plasmid were immuno-
blotted with the FLAG and 14-3-3b antibodies. (G)
E14 embryos were electroporated and analyzed
as in (D) with the PHF6 RNAi or control RNAi
plasmid together with an expression plasmid en-
coding wild-type or patient mutant (C99F or
deletion 279–365) PHF6-Res protein or the cor-
responding control vector. vec, control vector;
Res, PHF6-Res; del, deletion. (H) Quantification of
the percentage of GFP-positive neurons in distinct
regions of the cerebral cortex in E19mouse embryos treated as in (G) is presented asmean + SEM. Expression of PHF6-Res significantly reduced the percentage
of neurons stalled in the intermediate zone and significantly increased the percentage of neurons that reached the upper cortical plate in the background of PHF6
RNAi in the cerebral cortex in vivo (ANOVA, p < 0.05). The C99F mutation or deletion of amino acids 279–365 blocked the ability of PHF6-Res to drive neuronal
migration. See also Figure S1. Scale bars represent 3 mm in (C) and 50 mm in (D) and (G).
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file of PHF6 expression raised the possibility that PHF6 might
play a role in cortical development.
To determine PHF6 function in cortical development, we used
a plasmid-based method of RNA interference (RNAi) to acutely
knockdown PHF6 in the developing cerebral cortex (Gaudilliere
et al., 2002). Expression of three short hairpin RNAs (shRNAs)
targeting distinct regions of PHF6 mRNA induced knockdown
of exogenous PHF6 protein in 293T cells and endogenous
PHF6 in primary mouse cortical neurons (Figures 1A, 1B, S1D,
and S1E).
We next employed an in utero electroporation method to
induce knockdown of PHF6 in the developing mouse cerebral
cortex in vivo. The PHF6 RNAi plasmids were electroporatedtogether with a plasmid encoding GFP in the developing cortex
in mice at E14, when superficial layer neurons are generated.
Embryos were allowed to develop in utero until E19, and brains
were harvested and subjected to immunohistochemical ana-
lyses.Wefirst confirmed thatPHF6RNAi triggered thedownregu-
lation of endogenous PHF6 in the cerebral cortex in vivo (Figures
1C and S1F). Upon characterizing the consequences of PHF6
knockdown on cortical development, we found a striking migra-
tion phenotype. Neurons in control animals differentiated and
migrated properly to the superficial layers of the cortical plate.
By contrast, cortical neurons in PHF6 knockdown animals failed
to migrate to the proper location in the upper cortical plate (Fig-
ures 1D and 1E). PHF6 RNAi reduced the percentage of neurons
reaching the upper cortical plate by 2- to 3-fold and increased theNeuron 78, 986–993, June 19, 2013 ª2013 Elsevier Inc. 987
Figure 2. PHF6 Is Critical for Morphological Changes during
Neuronal Migration in the Cerebral Cortex In Vivo
(A) E14 embryos were electroporated as in Figure 1D and allowed to develop
until E17. The cerebral cortex was then subjected to immunohistochemistry
with the GFP antibody. CP, cortical plate. (B) Quantification of the percentage
of GFP-positive neurons in distinct regions of the cerebral cortex in E17mouse
embryos treated as in (A) is presented as mean + SEM. (C) E14 embryos were
electroporated and analyzed as in (A). Representative images for neurons in
the lower or upper intermediate zone are shown. loIZ, lower intermediate zone;
upIZ, upper intermediate zone. (D) Quantification of the percentage of GFP-
positive neurons in the intermediate zone exhibiting bipolar or multipolar
morphology in E17 mouse embryos treated as in (C) is presented as mean ±
SEM. (E) E14 embryos were electroporated as in (A) and allowed to develop
until E19. The cerebral cortex was then subjected to immunohistochemistry
with the GFP antibody. Representative images of migrating neurons in the
lower cortical plate are shown. The leading process is indicated by arrows. (F)
Quantification of the percentage of GFP-positive cells exhibiting different
leading process morphologies in E19 embryos treated as in (E) is presented as
mean ± SEM. Scale bar represents 50 mm in (A), 5 mm in (C), and 10 mm in (E).
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The extent of the migration defect correlated with the degree of
PHF6 knockdown (Figure 1A). In control analyses, PHF6 knock-
down had little or no effect on neuronal differentiation (Figure S1H
and data not shown), progenitor cell proliferation (Figure S1I),
general cell health (Figures S1J andS1K), ormorphology of radial
glial cells (data not shown). Together, these results suggest that
PHF6 knockdown specifically impairs the radial migration of
neurons in the developing cerebral cortex.
To determine whether the PHF6 RNAi-induced migration
phenotype is due to specific knockdown of PHF6, we performed
a rescue experiment. Expression of rat PHF6 (PHF6-Res), which
contains two mismatches with shRNA-2 targeting mouse PHF6,
was refractory to PHF6 RNAi (Figure 1F). Importantly, expression988 Neuron 78, 986–993, June 19, 2013 ª2013 Elsevier Inc.of PHF6-Res in PHF6 knockdown animals largely restored the
normal migration pattern of cortical neurons (Figures 1G and
1H). These data indicate that the PHF6 RNAi-induced migration
phenotype is the result of specific knockdown of PHF6.
We next asked whether the PHF6 knockdown-induced migra-
tion phenotype is relevant to intellectual disability. The patient
mutation C99F targets a conserved cysteine residue in PHF6’s
first PHD domain (Lower et al., 2002) and impaired the ability
of PHF6-Res to drive migration in the cerebral cortex in vivo in
the background of PHF6 RNAi (Figures 1G and 1H). Likewise,
deletion of the C-terminal 86 amino acids, which also causes
BFLS (Berland et al., 2011), impaired PHF6-dependent neuronal
migration (Figures 1G and 1H). These data suggest that impaired
neuronal migration might underlie the pathogenesis of BFLS.
Having established a critical role of PHF6 in neuronal migra-
tion, we next asked howPHF6 functions in neurons at the cellular
level. Radial neuronal migration in the cerebral cortex results
from major cell morphological rearrangements, including the
transition from multipolar to bipolar neuronal morphology in the
intermediate zone and extension of the leading process toward
the pia (Ayala et al., 2007; Kriegstein and Noctor, 2004; Nadara-
jah et al., 2001). Knockdown of PHF6 substantially increased
the number of multipolar neurons and concomitantly reduced
the number of bipolar neurons in the intermediate zone in the
cerebral cortex in E17 embryos (Figures 2A, 2B, and 2D). The
remaining bipolar neurons in the PHF6 knockdown embryos
harbored a thick leading process with numerous filopodia-like
protrusions (Figure 2C). In other analyses, PHF6 knockdown
dramatically increased the percentage of migrating neurons
that lacked a leading process or that had a short, poorly devel-
oped, or aberrantly branched leading process (Figures 2E and
2F). These data suggest that PHF6 plays a critical role in the
multipolar-to-bipolar transition and the morphogenesis of the
leading process in migrating neurons.
The PAF1 Complex Interacts with PHF6 and Plays a
Critical Role in Radial Migration of Neurons in the
Cerebral Cortex In Vivo
We next determined the mechanism by which PHF6 or-
chestrates neuronal migration. Immunocytochemical analyses
suggested that PHF6 protein localized to the nucleoplasm in pri-
mary cortical neurons, consistent with the possibility that PHF6
might regulate transcription (Figure S1G) (Lower et al., 2002).
Since PHF6 is not known to harbor enzymatic activity, we
reasoned that PHF6 might associate with other factors that in
turn regulate transcription. To identify proteins that physically
associate with PHF6, we used an approach of immunoprecipita-
tion followed by mass spectrometry (IP/MS). We used a rigorous
proteomics method that compares a specific IP/MS data set
against a large set of unrelated parallel IP/MS data sets, thus dis-
tinguishing high-confidence candidate interacting proteins
(HCIPs) from background proteins (Behrends et al., 2010; Litter-
man et al., 2011; Sowa et al., 2009). Remarkably, all four core
components of the PAF1 transcription elongation complex,
PAF1, LEO1, CDC73, and CTR9, were found as robust HCIPs
of PHF6 (Figure 3A).
We validated the interaction of HA-PHF6 and the endogenous
PAF1 complex in coimmunoprecipitation analyses in cells
Figure 3. The PAF1 Complex Interacts with
PHF6 and Plays a Critical Role in Radial
Migration of Neurons in the Cerebral Cortex
In Vivo
(A) Lysates of 293T cells stably expressing
N-terminally tagged HA-PHF6 were immunopre-
cipitated with the HA beads and subjected to
proteomic analyses using LC-MS/MS. Peptide
spectra were analyzed and scored using the
CompPASS software program. High-confidence
candidate interacting proteins (HCIPs) of PHF6 are
shown. Rows in pink denote components of the
PAF1 complex. (B) Lysates of 293T cells ex-
pressing HA-PHF6 or HA-GFP were subjected to
immunoprecipitation with the HA beads followed
by immunoblotting with the HA, PAF1, LEO1,
CDC73, and CTR9 antibodies. Input was also im-
munoblotted with the antibodies. (C) Lysates of
E17 mouse cerebral cortex were immunoprecipi-
tated with the PHF6 antibody or rabbit IgG
followed by immunoblotting with the PAF1, LEO1,
CDC73, CTR9, and PHF6 antibodies. Asterisk
denotes a nonspecific band. Rabbit IgG signal
from the PHF6 immunoblot is nonspecific immu-
noreactivity from the rabbit heavy chain. (D)
Lysates of primary rat cortical neurons or mouse
cerebral cortex were immunoblotted with the
PAF1, LEO1, CDC73, CTR9, and ERK antibodies.
(E) Lysates of mouse cortical neurons infected
with lentivirus expressing PAF1 shRNAs or control
shRNAs were immunoblotted with the PAF1 and
14-3-3b antibodies. (F) Lysates of Neuro2A cells
infected with lentivirus expressing PAF1 shRNAs
or control shRNAs were immunoblotted with the
PAF1, LEO1, CDC73, CTR9, and 14-3-3b anti-
bodies. (G) E14 embryos were electroporated with
an RNAi plasmid encoding PAF1 shRNAs or control shRNAs and analyzed as in Figure 1D. (H) Quantification of the percentage of GFP-positive neurons in distinct
regions of the cerebral cortex in E19 mouse embryos treated as in (G) is presented as mean + SEM. Scale bar represents 50 mm in (G).
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associated with all four components of the endogenous PAF1
complex in mouse cerebral cortex at E17, coinciding temporally
with migration of neurons to the superficial layers (Figure 3C).
These data suggest that the PAF1 complex might represent a
physiological interacting partner of PHF6.
The PAF1 transcription elongation complex was first identified
in yeast as an RNA polymerase II-associated complex and plays
a critical role in efficient transcriptional elongation along chro-
matin (Kim et al., 2010; Rondo´n et al., 2004; Shi et al., 1996).
All four components of the complex were highly expressed dur-
ing early development in primary cortical neurons and the cere-
bral cortex in vivo (Figure 3D). The role of the PAF1 complex in
the brain has remained unexplored.
We asked whether the PHF6-PAF1 interaction is functionally
relevant in neuronal migration. We reasoned that if PHF6 acts
via the PAF1 complex to regulate neuronal migration, loss of
PAF1 would be predicted to disrupt neuronal migration.
Consistent with this prediction, PAF1 knockdown by two distinct
shRNAs substantially impaired neuronal migration in the cerebral
cortex in vivo, phenocopying the effect of PHF6 knockdown (Fig-
ures 3E, 3F, 3G, and 3H). Notably, knockdown of PAF1 led to
downregulation of the other components of the PAF1 complex
(Figure 3F) (Chen et al., 2009), suggesting that the intact PAF1complex is required for proper neuronal migration. Collectively,
these data suggest that PHF6 physically associates with the
PAF1 complex and thereby drives neuronal migration.
The Neuroglycan C/Chondroitin Sulfate Proteoglycan 5
(NGC/CSPG5) Gene Is aKeyDownstreamTarget of PHF6
and PAF1 in the Control of Neuronal Migration In Vivo
The finding that PHF6 interacts with the PAF1 transcription
elongation complex and thereby promotes cortical neuronal
migration led us to determine whether PHF6 exerts its function
via regulation of gene expression. Because the PAF1 complex
promotes transcription, we reasoned that PHF6 might stimulate
the expression of genes that trigger neuronal migration. We
performed microarray analyses of control and PHF6 knock-
down primary cortical neurons. A large number of genes were
downregulated in cortical neurons upon PHF6 knockdown
(Table S1). Among downregulated genes that were validated
by RT-PCR analyses, NGC/CSPG5 was the most consistently
and robustly downregulated gene in PHF6 knockdown neurons
(Figures 4A and S2A). NGC/CSPG5 was also robustly downre-
gulated by PAF1 knockdown in primary cortical neurons, sug-
gesting that NGC/CSPG5 is coordinately regulated by PHF6
and the PAF1 transcription elongation complex (Figures 4B
and S2B).Neuron 78, 986–993, June 19, 2013 ª2013 Elsevier Inc. 989
Figure 4. The Neuroglycan C/Chondroitin Sulfate Proteoglycan 5
(NGC/CSPG5) Gene Is a Key Downstream Target of PHF6 and
PAF1 in the Control of Neuronal Migration In Vivo
(A) Quantitative RT-PCR analyses of primary rat cortical neurons infected with
lentivirus expressing PHF6 shRNAs or control shRNAs. Levels of PHF6 and
NGC/CSPG5 were normalized to GAPDH levels (n = 3). (B) Quantitative RT-
PCR analyses of primary rat cortical neurons infected with lentivirus ex-
pressing PAF1 shRNAs or control shRNAs. Levels of PAF1 and NGC/CSPG5
were normalized to GAPDH levels (n = 3). (C) Lysates of 293T cells transfected
with an expression vector encoding FLAG-NGC/CSPG5 together with an RNAi
plasmid encoding NGC/CSPG5 shRNAs or control shRNAs were immuno-
blotted with the FLAG and 14-3-3b antibodies. (D) E14 mouse embryos were
electroporated with an RNAi plasmid encoding NGC/CSPG5 shRNAs or
control shRNAs and analyzed as in Figure 1D. (E) Quantification of the per-
centage of GFP-positive neurons in distinct regions of the cerebral cortex in
E19 mouse embryos treated as in (D) is presented as mean + SEM. Knock-
down of NGC/CSPG5 also inhibited proliferation of cortical precursor cells
(see Figure S2F). (F) E14 mouse embryos were electroporated with the NGC/
CSPG5 RNAi or control RNAi plasmid together with an expression plasmid
encoding NGC-Res or its corresponding control vector and analyzed as in (D).
(G) Quantification of the percentage of GFP-positive neurons in distinct regions
of the cerebral cortex in E19 mouse embryos treated as in (F) is presented as
mean + SEM. Expression of NGC-Res significantly increased the percentage
of neurons reaching the upper cortical plate in the background of NGC/CSPG5
RNAi in the cerebral cortex in vivo (ANOVA, p < 0.05). (H) E14 mouse embryos
were electroporated with the PHF6 RNAi or control RNAi plasmid together with
an expression plasmid encoding NGC/CSPG5 or its corresponding control
vector and analyzed as in (D). (G) Quantification of the percentage of GFP-
positive neurons in distinct regions of the cerebral cortex in E19 mouse em-
bryos treated as in (H) is presented as mean + SEM. Expression of NGC/
CSPG5 significantly increased the percentage of neurons reaching the upper
cortical plate in the background of PHF6 RNAi in the cerebral cortex in vivo
(ANOVA, p < 0.01). See also Figure S2 and Table S1. Scale bars represent
50 mm in (D), (F), and (G).
Neuron
The PHF6/PAF1 Complex Drives Neuronal Migration
990 Neuron 78, 986–993, June 19, 2013 ª2013 Elsevier Inc.The NGC/CSPG5 gene is expressed in the brain (Figure S2C)
and encodes a transmembrane chondroitin sulfate glycoprotein
that is a member of the neuregulin family of proteins, which is
implicated in neuronal migration (Kinugasa et al., 2004; Rio
et al., 1997). Interestingly, the NGC/CSPG5 gene is a potential
susceptibility locus in schizophrenia, in which impaired neuronal
migration is thought to play a role (Impagnatiello et al., 1998; So
et al., 2010). These observations raised the possibility that NGC/
CSPG5 might represent a physiologically relevant downstream
target of the PHF6-PAF1 pathway in the control of neuronal
migration.
Knockdown of NGC/CSPG5 in mouse embryos using two
distinct shRNAs impaired neuronal migration in the cerebral cor-
tex in vivo (Figures 4C, 4D, 4E, and S2F), phenocopying the
PHF6 knockdown phenotype. The extent of the migration defect
correlated with the efficiency of NGC/CSPG5 knockdown.
Importantly, expression of an RNAi-resistant rescue form of
NGC/CSPG5 suppressed the NGC/CSPG5 RNAi-induced
phenotype, suggesting that the RNAi-induced migration defect
is the result of specific knockdown of NGC/CSPG5 (Figures
4F, 4G, and S2D). Remarkably, in epistasis analyses, expression
of exogenous NGC/CSPG5 in PHF6 knockdown animals largely
restored the normal migration pattern in the cerebral cortex
in vivo (Figures 4H, 4I, and S2E). Together, our data suggest
that NGC/CSPG5 represents a key target of PHF6 in the control
of cortical neuronal migration in vivo.
PHF6 Knockdown Triggers the Formation of White
Matter Heterotopias with Aberrant Neuronal Activity
Having elucidated a mechanism by which PHF6 orchestrates
neuronal migration in the developing cerebral cortex in vivo,
we next addressed the question of how loss of PHF6 might
contribute to the pathogenesis of BFLS. We asked whether
consequences of impaired migration upon PHF6 knockdown
persist beyond the formation of the cerebral cortex. We electro-
porated E14mouse embryos and examined animals at postnatal
day 6 (P6). In these analyses, almost all transfected neurons in
control animals resided in layers II–IV and expressed Cux1, a
marker of superficial layer neurons (Nieto et al., 2004). Strikingly,
neurons in PHF6 knockdown animals at P6 formed heterotopias
in the white matter and were also found ectopically in layers V–VI
(Figure 5A). Quantification revealed that 98% of Cux1-positive,
transfected cortical neurons reached layers II–IV in control ani-
mals, whereas only 32% of Cux1-positive, transfected neurons
reached the superficial layers in PHF6 knockdown animals (Fig-
ure 5B). The failure of PHF6 knockdown neurons to reach layers
II–IV in P6 animals was not due to impaired differentiation, as het-
erotopic neurons expressed Cux1 but not the layer V marker
Ctip2 (Figures 5C, S3A, and S3B). These data suggest that
loss of PHF6 triggers the formation of heterotopia in the cerebral
cortex in vivo.
We next examined the electrophysiological properties of
transfected neurons in acute cortical slices prepared from
P10 control or PHF6 knockdown animals. Under current-clamp
configuration, we observed an aberrant pattern of activity in
70% of heterotopic neurons, but not in neurons that reached
layers II–IV, in PHF6 knockdown animals (Figure 5D). The
membrane potential of heterotopic neurons oscillated, leading
Figure 5. PHF6 Knockdown Triggers the
Formation of White Matter Heterotopias
with Aberrant Neuronal Activity
(A) E14 mouse embryos were electroporated with
the RNAi plasmid encoding PHF6 shRNAs or
control shRNAs together with the GFP expression
plasmid and allowed to develop until P6. The ce-
rebral cortex from the P6 mouse pups was sub-
jected to immunohistochemical analyses with the
GFP and Cux1 antibodies. Arrowheads denote
heterotopic neurons in PHF6 knockdown animals.
WM, white matter. (B) Quantification of the per-
centage of GFP-positive, Cux1-positive neurons in
distinct regions of the cerebral cortex in P6 mouse
pups treated as in (A) is presented asmean + SEM.
(C) Representative image of heterotopic neurons
in the white matter in PHF6 knockdown animals.
GFP-positive neurons are positive for Cux1 (ar-
rows). (D) E14 mouse embryos were electro-
porated as in (A) and allowed to develop until P10.
Representative images for whole-cell recordings
in current clamp of GFP-positive neuron in cortical
slices from P10 PHF6 knockdown or control
mouse pups are shown. (E) Whole-cell recordings
were performed as in (D). Abnormal firing patterns
of heterotopic neurons are blocked by bath
application of 10 mM nimodipine. Left and right
panels are recordings from the same neuron
before and after adding the inhibitor. See also
Figure S3. Scale bars represent 100 mm in (A) and
30 mm in (C).
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aptic currents (sEPSCs) were observed in layer II–IV neurons
in control or PHF6 knockdown animals but were markedly
reduced in heterotopic neurons in PHF6 knockdown animals,
suggesting that the membrane potential of heterotopic
neurons may oscillate in the absence of synaptic inputs
(Figures S3C, S3D, and S3E). The membrane potential oscilla-
tion in heterotopic neurons was blocked by nimodipine, sug-
gesting that calcium currents might underlie the spontaneous
depolarization (Figure 5E). In other experiments, knockdown
of NGC/CSPG5 in E14 mouse embryos led to the formation
of white matter heterotopias in P10 mouse pups, whichNeuron 78, 986–9harbored a similar pattern of neuronal
activity as heterotopias in PHF6 knock-
down animals (Figure S3F). Together,
these data suggest that inhibition of the
PHF6 pathway triggers the formation
of heterotopias in which neurons are
hyperexcitable.
Collectively, we have identified a
transcriptional pathway whereby the
X-linked intellectual disability protein
PHF6 forms a complex with the PAF1
transcription elongation complex and
thereby induces the expression of
NGC/CSPG5, leading to the migration
of cortical neurons in the cerebral cortex.
Deregulation of this pathway may playa critical role in the pathogenesis of intellectual disability and
epilepsy in BFLS.
DISCUSSION
In this study, we have discovered an essential function for the
intellectual disability protein PHF6 in the development of the
cerebral cortex. Loss of PHF6 impairs neuronal migration and
leads to formation of heterotopia, accompanied by aberrant
neuronal activity patterns. We have also uncovered the mecha-
nism by which PHF6 orchestrates neuronal migration in the
cerebral cortex. PHF6 physically associates with the PAF193, June 19, 2013 ª2013 Elsevier Inc. 991
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required for neuronal migration. We have also identified NGC/
CSPG5, a potential susceptibility gene for schizophrenia, as a
critical downstream target of PHF6 and the PAF1 complex that
mediates PHF6-dependent neuronal migration. Together, our
data define PHF6, the PAF1 complex, and NGC/CSPG5 as com-
ponents of a cell-intrinsic transcriptional pathway that promotes
neuronal migration in the cerebral cortexwith pathophysiological
relevance to intellectual disability and epilepsy.
The identification of PHF6 function in neuronal migration in the
cerebral cortex advances our understanding of the pathogenesis
of intellectual disability in BFLS. We have found that the conse-
quences of impaired migration upon PHF6 inhibition persist
beyond corticogenesis. Consistent with our findings, rare neuro-
pathological studies of BFLS patients have revealed cortical
dysplasia, absent lamination, and white matter heterotopia
(Brun et al., 1974). Therefore, impaired neuronal migration and
associated heterotopias may play a key role in the pathogenesis
of intellectual disability in BFLS. In view of our findings, it will be
important to perform detailed imaging to characterize potential
heterotopias in BFLS patients. Heterotopias are associated
with epilepsy (Ackmanet al., 2009). Therefore, the hyperexcitabil-
ity of heterotopic PHF6 knockdown neurons suggests the possi-
bility that heterotopias may also contribute to epilepsy in BFLS.
The finding that the PAF1 complex interacts with PHF6 and
promotes neuronal migration in the cerebral cortex illuminates
a biological role for the PAF1 complex. Regulation of transcrip-
tional elongation is a fundamental aspect of gene expression
control (Levine, 2011; Muse et al., 2007). Our findings suggest
that the control of transcriptional elongationmay represent a crit-
ical point of regulation in neuronal migration, with relevance to
intellectual disability and epilepsy. Both PHF6 and the PAF1
complex have been implicated in the pathogenesis of leukemia
(Muntean et al., 2010; Van Vlierberghe et al., 2010). Thus, our
findings linking PHF6 and the PAF1 complex may also have ram-
ifications in cancer biology.
The identification ofNGC/CSPG5 as a key target gene of PHF6
and PAF1 has implications for the biology of both NGC/CSPG5
and PHF6. Since NGC/CSPG5might represent a potential locus
for schizophrenia (So et al., 2010), our findings raise the possibil-
ity that mutations of PHF6 may contribute to the pathogenesis of
neuropsychiatric disorders. Conversely, it will be interesting to
determine whether deregulation of NGC/CSPG5 might play a
role in intellectual disability and epilepsy. Intriguingly, NGC/
CSPG5 may have an additional function in neural progenitor
cell proliferation (Figure S2F), thoughwhether this potential func-
tion is regulated independently of PHF6 or relevant to brain dis-
orders remains to be determined. Because NGC/CSPG5 is a
transmembrane protein and a member of the neuregulin family
that can directly bind ErbB3 and transactivate ErbB2 (Kinugasa
et al., 2004), NGC/CSPG5 signalingmight represent an attractive
drug target in the treatment of intellectual disability.EXPERIMENTAL PROCEDURES
Animals
Timed pregnant CD-1 mice were purchased from Charles River Laboratories.
All animal experiments were conducted under the institutional guidelines992 Neuron 78, 986–993, June 19, 2013 ª2013 Elsevier Inc.and were approved by the Institutional Animal Care and Use Committee
(IACUC).
Plasmids
The PHF6 and NGC/CSPG5 expression plasmids were generated by PCR
using mouse or rat cortical neuron cDNA. The shRNA plasmid targeting
sequences are described in the Supplemental Experimental Procedures.
In Utero Electroporation
In utero electroporations were performed as described in Ge et al. (2010).
Briefly, venus plasmid (final concentration 0.5 mg/ml) was coinjected with the
RNAi plasmid (final concentration 2 mg/ml) into the lateral ventricle of E14
mouse embryos within the uterine sac, and electroporation was performed
(35 V for 50 ms, with 950 ms intervals, 6 pulses). The uterine sac was then
returned to the abdominal cavity and the abdominal wall was sutured. E19
embryos were harvested and fixed in 4% paraformaldehyde for 1 hr. P6 brains
were fixed by intracardiac perfusion using 4% paraformaldehyde followed by
postfixation in 4% paraformaldehyde for 2 hr. After fixation, brains were sub-
jected to cryoprotection in 30% sucrose in PBS overnight. Afterward, brains
were embedded in OCT and flash frozen, and 20 mm coronal sections were
prepared. At least three animals were analyzed for each condition. Immunohis-
tochemical analyses were then performed at indicated time points as
described in Ge et al. (2010).
Immunoprecipitation/Mass Spectrometry
To identify specificPHF6 interactors,wegenerated293Tcells stably expressing
N-terminally HA-tagged PHF6 using lentivirus followed by antibiotic selection.
Four confluent 15 cm dishes of stable PHF6-expressing cells were lysed in
0.5% Nonidet P40 and subjected to immunoprecipitation using anti-HA resin
(clone HA-7, Sigma). Immunoprecipitated PHF6 was eluted using HA peptide
(Anaspec), and the eluted proteins were precipitated with trichloroacetic acid
and digested with trypsin. The resulting tryptic peptides were desalted over
C18 resin and then loaded onto an LTQ linear ion trap mass spectrometer
(Thermo Finnigan) for LC-MS/MS analyses. MS/MS spectra were searched
using SEQUEST against a target-decoy database of tryptic peptides, and pro-
tein assignments were analyzed using the CompPASS software platform (Beh-
rends et al., 2010; Litterman et al., 2011; Sowa et al., 2009). Using CompPASS,
the uniqueness, abundance, and reproducibility of each protein assignment
was compared across parallel sets of MS data generated from multiple unre-
lated immunoprecipitations to distinguish high-confidence protein interactors
(HCIPs) from nonspecific interacting proteins. HCIPs have WDN-scores >1.0.
Immunoblotting
Immunoblotting was performed as described in Lehtinen et al. (2006).
RT-PCR
Primers used for RT-PCR are described in the Supplemental Experimental
Procedures.
Lentivirus Production
shRNA sequences were cloned into pLentiLox 3.7 vector and lentivirus
production was performed as described in Rubinson et al. (2003).
Microarray
Microarray analyses were performed using Affymetrix Rat Gene 1.1 ST Array
Strip and Affymetrix GeneAtlas microarray system. All procedures were
performed according to manufacturers’ manuals. Analysis was performed as
described in Wakamatsu et al. (2013). GEO accession number is GSE45953.
Electrophysiology
Acute cortical slices (350 mm) were prepared from the cerebral cortex of
P10–P12 mice. Acute slice preparation and whole-cell patch-clamp recording
were preformed as previously described in Debanne et al. (2008).
Statistics
Statistical analyses were performed using the Excel software program. Pair-
wise comparisons within two groups only were done using the t test. Pairwise
Neuron
The PHF6/PAF1 Complex Drives Neuronal Migrationcomparisons within multiple groups were done by ANOVA followed by the
Fisher’s PLSD post hoc test. Data are presented as the mean + SEM. ****p <
0.001; ***p < 0.005; **p < 0.01; *p < 0.05; NS, not significant. Asterisks in the
figures denote t test comparisons between experimental group and control
in each experiment.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2013.04.021.
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